Total Payments
$25,561
2024 Payments
$3,636
Companies
68
Transactions
322
Medicare Patients
1,634
Medicare Billing
$336,030
Payment Breakdown by Category
Other$11,730 (45.9%)
Food & Beverage$6,532 (25.6%)
Consulting$5,481 (21.4%)
Travel$1,364 (5.3%)
Education$453.75 (1.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $11,730 | 6 | 45.9% |
| Food and Beverage | $6,532 | 299 | 25.6% |
| Consulting Fee | $5,481 | 4 | 21.4% |
| Travel and Lodging | $1,364 | 8 | 5.3% |
| Education | $453.75 | 5 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| EMD Serono, Inc. | $9,372 | 16 | $0 (2023) |
| Seagen Inc. | $3,243 | 12 | $0 (2023) |
| Eisai Inc. | $2,198 | 9 | $0 (2024) |
| Astellas Pharma Global Development | $1,992 | 1 | $0 (2021) |
| Abbott Laboratories | $1,387 | 17 | $0 (2023) |
| Janssen Scientific Affairs, LLC | $953.75 | 1 | $0 (2023) |
| Amgen Inc. | $821.79 | 56 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $737.74 | 13 | $0 (2024) |
| Astellas Pharma US Inc | $660.18 | 5 | $0 (2024) |
| Cardiovascular Systems Inc. | $313.36 | 12 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,636 | 53 | Eisai Inc. ($2,010) |
| 2023 | $12,040 | 58 | EMD Serono, Inc. ($6,476) |
| 2022 | $3,362 | 30 | EMD Serono, Inc. ($2,794) |
| 2021 | $2,217 | 9 | Astellas Pharma Global Development ($1,992) |
| 2020 | $870.08 | 37 | CHIESI USA, INC. ($240.66) |
| 2019 | $805.99 | 59 | Amgen Inc. ($183.38) |
| 2018 | $2,221 | 55 | Abbott Laboratories ($1,349) |
| 2017 | $407.00 | 21 | Amgen Inc. ($266.21) |
All Payment Transactions
322 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $31.13 | General |
| 11/27/2024 | Genmab U.S., Inc. | Epkinly (Drug) | Food and Beverage | In-kind items and services | $116.55 | General |
| Category: Oncology | ||||||
| 11/27/2024 | SOBI, INC | SYNAGIS (Drug) | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: IMMUNOLOGY | ||||||
| 11/25/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: Oncology | ||||||
| 11/15/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $20.44 | General |
| Category: HORMONE THERAPY | ||||||
| 10/30/2024 | Novocure Inc. | Optune Lua (NovoTTF-200T) (Device) | Food and Beverage | Cash or cash equivalent | $15.39 | General |
| Category: Oncology | ||||||
| 10/29/2024 | SERVIER PHARMACEUTICALS LLC | Tibsovo (Drug) | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: Oncology | ||||||
| 10/04/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: ONCOLOGY | ||||||
| 10/01/2024 | ABBVIE INC. | ELAHERE (Drug) | Food and Beverage | In-kind items and services | $33.79 | General |
| Category: ONCOLOGY | ||||||
| 09/26/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: Oncology | ||||||
| 09/11/2024 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug) | Food and Beverage | In-kind items and services | $32.06 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 09/09/2024 | AngioDynamics, Inc. | ALPHAVAC (Device) | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: VIT | ||||||
| 08/16/2024 | TerSera Therapeutics LLC | Zoladex (Drug) | Food and Beverage | In-kind items and services | $27.36 | General |
| Category: Oncology | ||||||
| 08/13/2024 | Incyte Corporation | PEMAZYRE (Drug), MONJUVI | Food and Beverage | Cash or cash equivalent | $18.33 | General |
| Category: Hepatology (Liver, Pancreatic, Gall Bladder) | ||||||
| 08/12/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: Oncology | ||||||
| 08/02/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $23.57 | General |
| Category: ONCOLOGY | ||||||
| 07/30/2024 | SOBI, INC | GAMIFANT (Drug) | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: HEMATOLOGY | ||||||
| 07/29/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: ONCOLOGY | ||||||
| 07/26/2024 | Pharmacosmos Therapeutics Inc. | MONOFERRIC (Drug) | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: HEMATOLOGY | ||||||
| 07/24/2024 | Genmab U.S., Inc. | Epkinly (Drug) | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: Oncology | ||||||
| 07/23/2024 | Genentech USA, Inc. | Polivy (Biological) | Food and Beverage | In-kind items and services | $22.76 | General |
| Category: BioOncology | ||||||
| 07/17/2024 | SpringWorks Therapeutics, Inc. | OGSIVEO (Drug) | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: DESMOID TUMORS | ||||||
| 07/12/2024 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $22.78 | General |
| Category: Oncology | ||||||
| 07/10/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $28.96 | General |
| 06/25/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Consulting Fee | Cash or cash equivalent | $525.00 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 542 | 1,100 | $317,253 | $122,797 |
| 2022 | 7 | 563 | 1,140 | $298,576 | $122,235 |
| 2021 | 7 | 357 | 654 | $169,356 | $66,955 |
| 2020 | 7 | 172 | 377 | $92,815 | $24,044 |
Total Patients
1,634
Total Services
3,271
Medicare Billing
$336,030
Procedure Codes
32
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 147 | 549 | $188,307 | $71,577 | 38.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 91 | 121 | $29,403 | $10,864 | 36.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 62 | 62 | $26,102 | $10,253 | 39.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 71 | 152 | $20,824 | $9,275 | 44.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 60 | 99 | $19,701 | $8,909 | 45.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 63 | 64 | $24,256 | $8,565 | 35.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 16 | 16 | $4,144 | $1,605 | 38.7% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 11 | 12 | $2,916 | $1,132 | 38.8% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2023 | 21 | 25 | $1,600 | $616.50 | 38.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 129 | 492 | $144,746 | $61,930 | 42.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 99 | 99 | $39,159 | $14,950 | 38.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 101 | 160 | $34,780 | $14,228 | 40.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 78 | 81 | $31,289 | $12,177 | 38.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 61 | 122 | $24,385 | $9,480 | 38.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 84 | 167 | $23,091 | $8,992 | 38.9% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2022 | 11 | 19 | $1,126 | $476.81 | 42.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 44 | 132 | $36,036 | $17,954 | 49.8% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 81 | 81 | $31,671 | $13,159 | 41.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 46 | 135 | $33,978 | $9,867 | 29.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 39 | 87 | $17,718 | $6,916 | 39.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 48 | 60 | $12,120 | $5,851 | 48.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 39 | 96 | $15,540 | $5,311 | 34.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 26 | 26 | $10,114 | $4,006 | 39.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 20 | 22 | $7,164 | $2,302 | 32.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 14 | 15 | $5,015 | $1,591 | 31.7% |
About Dr. Vikas Singh, MD
Dr. Vikas Singh, MD is a Internal Medicine healthcare provider based in Louisville, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/08/2012. The National Provider Identifier (NPI) number assigned to this provider is 1124375134.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Vikas Singh, MD has received a total of $25,561 in payments from pharmaceutical and medical device companies, with $3,636 received in 2024. These payments were reported across 322 transactions from 68 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($11,730).
As a Medicare-enrolled provider, Singh has provided services to 1,634 Medicare beneficiaries, totaling 3,271 services with total Medicare billing of $336,030. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Hematology & Oncology
- Location Louisville, KY
- Active Since 08/08/2012
- Last Updated 04/06/2018
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1124375134
Products in Payments
- BAVENCIO (Drug) $6,476
- PADCEV (Biological) $3,297
- Bavencio (Drug) $2,771
- Lenvima (Drug) $2,131
- PADCEV (Drug) $2,018
- Mitra Clip system (Device) $1,144
- Padcev (Drug) $595.00
- IMFINZI (Biological) $525.00
- Neulasta (Biological) $300.83
- AMPLATZER Occluders (Device) $205.63
- Coronary Orbital Atherectomy System (Device) $204.17
- KENGREAL 50MG/10ML L (Drug) $203.28
- MICRA (Device) $189.71
- (6554) Peripheral Vascular Undivided (Device) $167.26
- Epkinly (Drug) $133.43
- XGEVA (Biological) $132.05
- ZYTIGA (Drug) $109.70
- TEPMETKO (Drug) $107.00
- Peripheral Orbital Atherectomy System (Device) $98.29
- Abraxane (Drug) $94.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Louisville
Hisham Alrefai, Md, MD
Internal Medicine — Payments: $1.1M
Internal Medicine $1.1M
Dr. Matthew Cave, M.d, M.D
Internal Medicine — Payments: $373,716
Internal Medicine $373,716
Dr. Daniel Stewart, M.d, M.D
Internal Medicine — Payments: $284,815
Internal Medicine $284,815
Dr. Jaspreet Grewal, M.d., M.p.h, M.D., M.P.H
Internal Medicine — Payments: $262,625
Internal Medicine $262,625
Mohamed Hegazi, Md, MD
Internal Medicine — Payments: $244,885
Internal Medicine $244,885
Dr. Dawn Caster, M.d, M.D
Internal Medicine — Payments: $158,400
Internal Medicine $158,400